Opsens Inc CEO Louis Laflamme joined Steve Darling from Proactive to share news about the company that has had its OptoWire used in more than 200,000 cardiology patients in more than 30 countries. That product is using their fiber optic sensing technology.
Laflamme talks more about the product and also the the SavvyWire which is used for transcatheter aortic valve replacement procedures in U.S., Canada and New Zealand. The company has just begun the first commercial steps for that product.
#proactiveinvestors #opsensinc #tsx #ops #otcqx #opssf #pharma
#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
source